CyberKnife Market Size & Growth Forecast 2027–2036, By Segments (End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
CyberKnife Market size was assessed at USD 922.8 million in 2026 and is poised to grow at a 16.72% CAGR between 2027 and 2036, attaining USD 4.33 billion by 2036. The industry revenue for 2027 is calculated at USD 1.05 billion.
Get more details on this report
Request Free Sample ReportCyberKnife Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with 43.99% share due to advanced radiation oncology infrastructure, high system integration in cancer care, and strong concentration of specialized treatment centers and clinicians.
- Asia Pacific grows at 19.49% CAGR driven by expanding oncology facilities, rising cancer care investments, and increasing use of non-invasive radiosurgery in urban healthcare networks.
Segment Momentum
- Hospitals lead with 53.76% share due to strong multidisciplinary oncology infrastructure, advanced imaging systems, and referral networks supporting complex radiosurgery and high-acuity patient management across treatment pathways.
- Vascular malformation is the fastest-growing application as CyberKnife enables precise, non-invasive targeting of sensitive vascular structures, supporting safer treatment options where conventional interventions are more complex.
Market Expansion Drivers
- Increasing global cancer prevalence accelerating demand for non-invasive robotic radiosurgery treatments.
- Technological advancements and new CyberKnife system launches improving treatment precision and efficiency.
- Growing preference for minimally invasive oncology procedures expanding hospital adoption of CyberKnife systems.
Leading Market Participants
- Prominent companies in the CyberKnife market include Accuray Incorporated (United States), Elekta AB (Sweden), Varian Medical Systems, Inc. (United States), Siemens Healthineers AG (Germany), United Imaging Healthcare Co., Ltd. (China), ViewRay Technologies, Inc. (United States), Brainlab AG (Germany), Hitachi, Ltd. (Japan), RaySearch Laboratories AB (Sweden).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 922.8 million
- 2027 Estimated Market Size: USD 1.05 billion.
- Projected Market Size: USD 4.33 billion by 2036
- Growth Forecast: 16.72% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Hospitals (End-use) | Cancer (Application)
- Emerging Opportunity Segment: Outpatient Facilities (End-use) | Vascular Malformation (Application)
Market Growth Drivers and Industry Trends
Increasing global cancer prevalence accelerating demand for non-invasive robotic radiosurgery treatments
The rising burden of cancer worldwide is creating greater demand for advanced treatment approaches, and increasing global cancer prevalence will drive the CyberKnife market growth by expanding the need for precise radiation-based interventions. Robotic radiosurgery enables clinicians to deliver highly focused radiation to tumors while limiting exposure to surrounding healthy tissues, making it particularly relevant for patients seeking treatment options with reduced invasiveness compared with conventional surgical procedures. Its ability to address tumors in anatomically sensitive or difficult-to-reach locations also broadens its clinical applicability across oncology settings. As cancer care increasingly emphasizes treatment precision, patient comfort, and reduced procedural burden, healthcare providers are incorporating robotic radiosurgery into multidisciplinary treatment pathways.
Technological advancements and new CyberKnife system launches improving treatment precision and efficiency
Continuous innovation in robotic radiation technology is strengthening the capabilities of modern radiosurgery platforms, with technological advancements and new system launches expected to propel the CyberKnife market growth. Improvements in image guidance, robotic motion control, treatment planning, and real-time tumor tracking can enable radiation delivery to be adjusted according to patient and tumor movement during treatment. These capabilities support more accurate targeting while helping clinicians optimize treatment workflows and reduce unnecessary radiation exposure to adjacent tissues. Enhanced software integration and automated planning features can also simplify treatment preparation and improve operational efficiency, encouraging healthcare institutions to consider newer systems when upgrading or expanding their radiation oncology infrastructure.
Growing preference for minimally invasive oncology procedures expanding hospital adoption of CyberKnife systems
A broader shift toward less invasive cancer treatment is encouraging hospitals to adopt technologies that can deliver therapeutic outcomes without conventional open surgery, thereby supporting the CyberKnife market growth. Robotic radiosurgery can provide highly targeted treatment with limited physical intervention, which may reduce recovery requirements and make treatment more suitable for selected patients who are not ideal candidates for traditional surgery. The ability to perform certain procedures on an outpatient or short-stay basis can further align with healthcare providers' efforts to improve patient throughput and resource utilization. Growing attention to patient-centered oncology care, particularly procedures that minimize discomfort and disruption to daily activities, is strengthening the role of robotic radiosurgery within hospital-based cancer treatment programs.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Increasing global cancer prevalence accelerating demand for non-invasive robotic radiosurgery treatments | 2.20% | High | North America, Asia Pacific | High | Near Term |
| Technological advancements and new CyberKnife system launches improving treatment precision and efficiency | 1.80% | High | North America, Europe | High | Mid Term |
| Growing preference for minimally invasive oncology procedures expanding hospital adoption of CyberKnife systems | 1.50% | Moderate | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America dominated the CyberKnife market, accounting for 43.99% share in 2026. The region’s strong position is supported by advanced radiation oncology infrastructure, widespread availability of specialized treatment centers, and established adoption of precision-based cancer care technologies. Increasing preference for non-invasive and highly targeted treatment approaches is encouraging the use of robotic radiosurgery systems, while investments in sophisticated healthcare facilities and specialist expertise further strengthen regional demand.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is the fastest-growing region, supported by expanding cancer care infrastructure, improving access to advanced radiation therapy, and rising healthcare investment. Growing awareness of precision oncology and increasing demand for less invasive treatment options are encouraging healthcare providers to adopt sophisticated radiosurgery technologies. The modernization of hospitals and broader development of specialized cancer treatment capabilities are creating favorable conditions for continued regional expansion.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants/Startups i Scale Low Medium High | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Precision Oncology IntegrationGermany incorporates CyberKnife systems into specialized cancer treatment centers with a strong emphasis on precision radiation therapy. Healthcare providers focus on expanding access to highly targeted treatment approaches while optimizing clinical efficiency and patient outcomes.
France 🇫🇷
Multidisciplinary Oncology ServicesFrance supports the CyberKnife market through coordinated oncology programs that integrate advanced radiosurgery with broader cancer treatment strategies. Clinical priorities include accurate tumor targeting, reduced treatment burden, and collaborative care planning across specialized medical teams.
Italy 🇮🇹
Hospital Technology ModernizationItaly continues incorporating CyberKnife technology into tertiary care hospitals as part of broader oncology service modernization. Healthcare institutions prioritize precision treatment capabilities, multidisciplinary clinical collaboration, and expanded availability of non-invasive therapeutic options for complex cancer cases.
Japan 🇯🇵
Specialized Cancer CareJapan utilizes CyberKnife technology to support minimally invasive treatment for complex neurological and oncological conditions. Hospitals in Japan emphasize treatment precision, patient comfort, and integration of advanced radiosurgery into comprehensive cancer care pathways.
South Korea 🇰🇷
Technology-Enabled Treatment CentersSouth Korea continues strengthening the CyberKnife market through investment in advanced oncology infrastructure and specialized treatment facilities. Healthcare providers emphasize precision therapy, efficient treatment planning, and expanded access to innovative radiation technologies for appropriate patient populations.
United States 🇺🇸
Advanced Radiosurgery AdoptionThe U.S. CyberKnife market benefits from broad adoption of precision radiosurgery for complex oncology treatments across major healthcare institutions. Providers in the U.S. prioritize non-invasive treatment options, multidisciplinary cancer care, and technology upgrades that improve clinical workflow and treatment accuracy.
Segment Leadership and Growth Trends
CyberKnife Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Hospitals (Largest Segment) vs Outpatient Facilities (Fastest-Growing Segment)
Hospitals held the largest share of 53.76% in 2026 in the CyberKnife market, reflecting their established role in providing advanced radiation-based cancer treatment and managing complex patient cases. Hospitals generally have the specialized infrastructure, multidisciplinary clinical teams, and treatment capabilities required to operate sophisticated robotic radiosurgery systems. The concentration of advanced oncology services within hospital settings continues to support the adoption of CyberKnife technology where precision treatment and specialized care are priorities.
Outpatient facilities are emerging as the fastest-growing segment as healthcare delivery increasingly shifts toward less intensive treatment settings that can provide specialized procedures with greater convenience and efficient resource utilization. The ability of robotic radiosurgery to deliver highly targeted treatments supports its suitability for selected outpatient care pathways. Growing demand for accessible oncology services and the broader movement toward ambulatory treatment models are encouraging greater consideration of CyberKnife systems outside traditional hospital environments.
Application Segment Analysis: Cancer (Largest Segment) vs Vascular Malformation (Fastest-Growing Segment)
Cancer accounted for the largest share of 46.43% in 2026 in the CyberKnife market, driven by the broad use of precise radiation treatment for tumors across different anatomical locations. CyberKnife technology is particularly suited to applications requiring highly targeted radiation delivery while minimizing exposure to surrounding healthy tissue. Increasing demand for non-invasive and precision-focused cancer treatment approaches continues to reinforce the importance of oncology applications within the market.
Vascular malformation is the fastest-growing application as precision radiosurgery gains greater relevance for treating abnormal blood-vessel formations where accurate radiation delivery is essential. The ability to focus treatment on targeted lesions while limiting unnecessary exposure to adjacent structures supports the use of CyberKnife technology in these complex conditions. Growing clinical interest in non-invasive treatment alternatives and advances in image-guided radiosurgery are further strengthening adoption in vascular applications.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Outpatient Facilities, Research & Manufacturing | Hospitals | Outpatient Facilities |
| Application | Tumor, Cancer, Vascular Malformation, Others | Cancer | Vascular Malformation |
Competitive Landscape and Market Positioning
Prominent players in the CyberKnife market:
1. Accuray Incorporated (United States)
2. Elekta AB (Sweden)
3. Varian Medical Systems Inc. (United States)
4. Siemens Healthineers AG (Germany)
5. United Imaging Healthcare Co. Ltd. (China)
6. ViewRay Technologies Inc. (United States)
7. Brainlab AG (Germany)
8. Hitachi Ltd. (Japan)
9. RaySearch Laboratories AB (Sweden)
The CyberKnife market is witnessing increasing emphasis on precision-focused cancer treatment technologies and non-invasive therapeutic solutions. Industry participants are integrating advanced imaging systems, robotic targeting capabilities, and treatment planning software to improve clinical accuracy and patient outcomes. Continuous research activity and technological refinement aimed at expanding treatment applications are further strengthening innovation within the radiotherapy landscape.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Accuray Incorporated (United States) | |||||||
| Elekta AB (Sweden) | |||||||
| Varian Medical Systems Inc. (United States) | |||||||
| Siemens Healthineers AG (Germany) | |||||||
| United Imaging Healthcare Co. Ltd. (China) | |||||||
| ViewRay Technologies Inc. (United States) | |||||||
| Brainlab AG (Germany) | |||||||
| Hitachi Ltd. (Japan) | |||||||
| RaySearch Laboratories AB (Sweden). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Asian Hospital Inc. | Mar-26 | Asian Hospital received Board of Investments approval for a dedicated robotic treatment facility to house its CyberKnife radiotherapy service. This infrastructure investment significantly bolsters the facility's precision oncology capabilities and expands clinical access to stereotactic radiosurgery-based cancer treatments within the region. |
| SEHA | Nov-25 | SEHA successfully commissioned the first CyberKnife installation at Tawam Hospital in Abu Dhabi. This deployment represents a critical enhancement to the UAE's advanced oncology infrastructure, enabling high-precision, non-invasive radiation delivery for complex cancer cases and establishing a new standard for stereotactic radiosurgery within the regional healthcare system. |
| Asian Hospital and Medical Center | Sep-25 | Asian Hospital integrated CyberKnife-based radiotherapy technology with real-time tumor tracking capabilities into its oncology department. By enabling adaptive, non-invasive radiation delivery, the system improves treatment precision for diverse tumor types, reflecting the broader clinical shift toward automated, image-guided stereotactic radiosurgery in oncology workflows. |
| Accuray Incorporated | Jan-25 | Accuray Incorporated secured approval from China’s National Medical Products Administration for its Radixact SynC and CyberKnife S7 systems. This regulatory milestone enables the company to expand its installed base and commercial footprint in the high-growth Chinese radiotherapy market, facilitating broader access to advanced, robotic-assisted cancer treatment technologies. |
| HCG Cancer Centre | Sep-24 | HCG Cancer Centre commissioned an AI-driven CyberKnife S7 system, leveraging real-time motion adaptation and automated delivery protocols. This technological adoption marks a significant advancement in robotic radiosurgery, providing improved operational efficiency and clinical precision for both malignant and non-malignant tumor treatments compared to legacy radiotherapy systems. |
| Heidelberg University Hospital | Jun-24 | Heidelberg University Hospital integrated the Radixact System into its radiotherapy department, augmenting its cancer treatment portfolio with advanced technology from Accuray Incorporated. This procurement demonstrates the ongoing adoption of sophisticated, automated radiation therapy platforms in leading European academic medical centers, aimed at enhancing personalized treatment precision and patient outcomes. |
| Kenyatta University Teaching, Referral, and Research Hospital | Sep-23 | The commissioning of a CyberKnife radiotherapy system at Kenyatta University Teaching, Referral, and Research Hospital represents a landmark development as the first such system in Sub-Saharan Africa. This infrastructure investment serves to bridge a major technological gap in regional oncology, significantly expanding access to high-precision, non-invasive cancer care. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
CyberKnife Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Healthcare Provider Ownership | Public Hospitals, Private Hospitals & Specialty Centers, Academic & Research Hospitals |
| Patient Volume | Low-Volume Centers, Medium-Volume Centers, High-Volume Centers |
| Reimbursement Model | Public Insurance & Government Reimbursement, Private Insurance Reimbursement, Self-Pay & Direct Payment |
CyberKnife Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Opportunity Assessment |
|
| Hospital Investment Decision Framework |
|
| Reimbursement Landscape Evaluation |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of CyberKnife?
How is the CyberKnife industry projected to perform over the next decade?
How is rising cancer prevalence influencing hospital investment and treatment capacity planning in the CyberKnife market?
How are technological improvements and minimally invasive care trends shaping adoption of CyberKnife systems?
Why do hospitals hold the largest share in the CyberKnife market?
What is driving growth in vascular malformation applications?
Why does North America lead the CyberKnife market?
What is driving CyberKnife adoption in Asia Pacific?
Which organizations are considered leaders in the CyberKnife landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization